Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Tag: Clinical trial

December 21, 2021 CD as API / Pharma applications

Cyclo Therapeutics Appoints Caroline Hastings, M.D. as Global Principal Investigator for Ongoing TransportNPC™ Study Evaluating Trappsol® Cyclo™ for the Treatment of Niemann-Pick Disease

Dec 9, 2021 – Dr. Hastings is a world-renowned Key Opinion Leader for Niemann-Pick Disease Type C1 and the first

Continue reading

December 7, 2021 CD as API / CD derivatives / Pharma applications

Cyclo Therapeutics Receives IND Clearance from the U.S. FDA to Advance its Phase 2 Study of Trappsol® Cyclo™ for the Treatment of Alzheimer’s Disease

Cyclo Therapeutics, Inc. (Nasdaq: CYTH) (“Cyclo Therapeutics” or the “Company”), a clinical stage biotechnology company dedicated to developing life-changing medicines through

Continue reading

November 18, 2021 CD as API / CD derivatives / Pharma applications

Cyclo Therapeutics Submits IND Application to U.S. FDA to Advance Trappsol® Cyclo™ in Phase 2 Study for Treatment of Alzheimer’s Disease

Cyclo Therapeutics, Inc., a clinical stage biotechnology company dedicated to developing life-changing medicines through science and innovation for patients and

Continue reading

November 11, 2021 Life sciences / Pharma applications

Role of HPBCD in development of Pfizer’s novel COVID-19 oral antiviral treatment candidate

Pfizer’s breakthrough drug candidate PF-07321332 used in combination with ritonavir was poven to successfully reduce the risk of hospitalization and

Continue reading

September 22, 2021 Drug delivery / Pharma applications

Updates on development of oral remdesivir formulations

Jubilant Pharmova subsidiary Jubilant Pharma has concluded safety and pharmacokinetic/absorption studies of a new oral formulation of remdesivir in animals

Continue reading

September 7, 2021 Drug delivery / Pharma applications

Use of ivermectin in the treatment of Covid-19: A pilot trial

As repurposing ivermectin against Covid-19 is still in the focus of debates and as this drug can be formulated with

Continue reading

August 26, 2021 CD as API / CD derivatives / Pharma applications

Aequus and reVision to Collaborate on Stargardt Disease Program using SBECD as active

Aequus Pharmaceuticals Inc. and reVision Therapeutics, Inc. (“reVision”) announced a collaboration on the development of a therapy for Stargardt disease.

Continue reading

June 21, 2021 CD as API / Pharma applications

Mallinckrodt gave up further development of adrabetadex (VTS-270; HPBCD)

Mallinckrodt Pharmaceuticals has reached an agreement to divest and transfer the Investigational New Drug (IND) application for experimental drug adrabetadex

Continue reading

May 13, 2021 CD as API / CD derivatives / Pharma applications

Clinical trial: Safety, Efficacy and Pharmacokinetics of CBT-006 in Patients With Meibomian Gland Dysfunction

CBT-006 is a molecule developed by Cloudbreak Therapeutics that can sequester cholesterol. CBT-006 is a unique topical formulation following 505b(2)

Continue reading

May 6, 2021 CD derivatives / Drug delivery / Pharma applications / Supramolecular systems

OCULIS ANNOUNCES AN OVERSUBSCRIBED US$57 MILLION SERIES C FINANCING

New leading international life science investors join current institutional investors with proceeds to:  Advance novel, late-stage Investigational ophthalmology drugs OCS-01

Continue reading

Posts navigation

1 2 3 … 8 Next Posts»

Recent Posts

  • Special issue: Recent Insights in Chemistry and Technology of Cyclodextrins
  • Special issue: Cyclodextrins as building blocks for new materials
  • Matthieu SOLLOGOUB at ICS 20
  • CicloTech®, a new platform to improve trans-ungual drug release
  • Prof. Kohzo Ito at ICS 20

Tags

antiviral Biotechnology Cancer therapy Captisol Cholesterol Clinical trial conference coronavirus Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems FDA Food Gilead History HPBCD Nanoparticles nanotechnology Niemann Pick Disease RAMEB remdesivir SBECD Special issue Sugammadex Synthesis Trappsol wastewater treatment

Follow Us

  • LinkedIn
  • Twitter
  • Facebook

Categories

  • Agriculture (13)
  • Analysis (27)
  • CD as API (177)
  • CD derivatives (229)
  • Cosmetics and toilettry (18)
  • Drug delivery (347)
  • E-ducation (49)
  • Environmental (62)
  • Events (149)
  • Food (100)
  • Gene delivery (8)
  • In Hungarian (4)
  • Life sciences (8)
  • Non-pharma applications (166)
  • Other industrial use (51)
  • Pharma applications (586)
  • Supramolecular systems (19)
  • Uncategorized (33)

Top Posts

  • Special issue: Recent Insights in Chemistry and Technology of Cyclodextrins
  • CicloTech®, a new platform to improve trans-ungual drug release
  • How air fresheners work?
  • Matthieu SOLLOGOUB at ICS 20
  • Special issue: Cyclodextrins as building blocks for new materials
  • Use of cyclodextrins as agrochemical delivery system
  • Practical Considerations about the Cyclodextrin Solubilities – A Quickstart Guide for Newbies
  • "NON-PHARMA USES OF CYCLODEXTRINS: Food; Nutraceuticals, Environmental and Other Industries, Agriculture” (webinar)
  • ICS2020 in Sicily concluded
  • Prof. Kohzo Ito at ICS 20

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 450 other subscribers

 

Loading Comments...